There is a negligible risk of transmitting HIV during sex when a person living with HIV is on antiretroviral therapy and maintains a viral load under a specific threshold, according to a study in CMAJ (Canadian Medical Association ...
Nov 19, 2018
0
3
Mechanisms that govern HIV transcription and latency differ in the gut and blood, according to a study published November 15 in the open-access journal PLOS Pathogens by Steven Yukl of San Francisco Veterans Affairs Medical ...
Nov 15, 2018
0
37
The latest World Health Organization (WHO) recommendations published in July 2018 advocate first-line treatment of HIV infection using dolutegravir (DTG) as an alternative to treatment with efavirenz at 400 mg (EFV400). Until ...
Nov 1, 2018
0
0
A United Nations initiative backed by global experts has set its sights on an ambitious programme to bring an end to the AIDS epidemic by 2030.
Oct 23, 2018
0
0
Immunotherapy has been a major breakthrough in oncology, with registered drugs now approved for use in an increasing number of tumour types—but little is known about its safety for HIV-positive cancer patients. A study ...
Oct 20, 2018
0
0
Thanks to improvements in antiretroviral therapy, HIV is now a manageable condition. Yet even the best drugs do not entirely eliminate the virus, which latently lingers in the body, threatening to rise to dangerous levels ...
Sep 26, 2018
0
95
A clinical trial testing infusions of combination antibodies in people living with HIV has begun at the National Institutes of Health. The early-phase clinical trial will evaluate whether periodic infusions of two highly ...
Sep 20, 2018
0
0
The fight against epidemics such as AIDS and tuberculosis needs greater funding and cooperation in order to wipe out the diseases, a leading aid group said Wednesday.
Sep 12, 2018
0
1
A relatively simple effort to provide counseling and connect injection-drug users with resources could prove powerful against the spread of HIV in a notoriously hard-to-reach population, new research suggests.
Aug 30, 2018
0
2
Immune activation and inflammation persist in the majority of treated HIV-infected individuals and is associated with excess risk of mortality and morbidity. A new study by Boston University School of Medicine (BUSM) researchers ...
Aug 27, 2018
0
10
